Recombinant Human UCHL3 Protein，His

UCHL3 (Ubiquitin C-terminal hydrolase L3) is a member of the ubiquitin-specific protease family, which plays a crucial role in the ubiquitin-proteasome system responsible for protein degradation and regulation. Recent studies have highlighted UCHL3's involvement in various cellular processes, including protein homeostasis, cell cycle regulation, and stress response, making it a significant player in both normal physiology and disease states. Its potential links to neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, where ubiquitin-dependent pathways are often disrupted, have spurred interest in its functional mechanisms. Additionally, UCHL3 has been shown to regulate the stability and activity of key signaling proteins, thereby influencing cellular signaling pathways. The development and characterization of recombinant UCHL3 protein are essential for elucidating its biochemical properties and understanding its interaction with various substrates. By generating a reliable source of recombinant UCHL3, researchers aim to facilitate in vitro studies that can unveil its role in cellular homeostasis and pathology, paving the way for novel therapeutic strategies targeting UCHL3 in various diseases. The ongoing research into UCHL3 not only enhances our comprehension of ubiquitin-mediated proteolysis but also opens new avenues for developing specific inhibitors or activators that could modulate its activity for therapeutic interventions.